Effects of Combined Administration of Alfacalcidol and Risedronate on Cancellous and Cortical Bone Mass of the Tibia in Glucocorticoid-Treated Young Rats

Jun Iwamoto；Azusa Seki；Tsuyoshi Takeda；Harumoto Yamada；Yoshihiro Sato；James K. Yeh

glucocorticoid ； osteopenia ； risedronate ； alfacalcidol ； rat

The Chinese Journal of Physiology

51卷3期（2008 / 06 / 30）

121 - 128

英文

The purpose of the present study was to examine the effects of combined administration of alfacalcidol (ALF) and risedronate (RIS) on cancellous and cortical bone mass of the tibia in glucocorticoid (GC)-treated young rats. One hundred and nine female Sprague-Dawley rats, 3 months of age, were randomly divided by the stratified weight method into eleven groups according to the following treatment schedule: baseline control, a 4-week age-matched control, and a 4-week GC administration with a 4-week concomitant administration of vehicle, ALF, RIS, or ALF+RIS, and an 8-week age-matched control and 8-week GC administration with a 4-week administration of vehicle, ALF, RIS, or ALF+RIS that was initiated after a 4-week administration of GC. The GC (methylprednisolone sodium succinate, 5.0 mg/kg) and RIS (10μg/kg) were administered subcutaneously 3 times a week. ALF (0.08μg/kg) was administered orally 5 times a week. At the end of the experiment, static and dynamic bone histomorphometric analyses were performed on cancellous bone of the proximal tibial metaphysis and cortical bone of the tibial diaphysis. A 4-week GC administration induced a loss of cancellous bone volume/total tissue volume (BV/TV) compared with the age-matched control as a result of decreased bone formation and increased bone erosion, while an 8-week GC administration induced both losses of cancellous BV/TV and of percent cortical area (Ct Ar) compared with the age-matched control as a result of decreased trabecular bone formation and increased trabecular and endocortical bone erosion. ALF prevented the loss of cancellous BV/TV at the 4th week by mildly suppressing bone erosion without reducing bone formation, and it restored cancellous BV/TV and increased percentage of Ct Ar at the 8th week by preventing a reduction in trabecular bone formation and mildly suppressing trabecular bone erosion and by strongly suppressing endocortical bone erosion, respectively. RIS restored only cancellous BV/TV at 8 weeks by strongly suppressing bone formation and bone erosion. Combined administration of ALF and RIS increased total tissue area of cortical bone at the 4th and 8th weeks by markedly increasing periosteal bone formation. The present study showed the efficacy of combined administration of ALF and RIS for the geometry of cortical bone in GC-treated rats.

1. Erben, R.G.(1997).Embedding of bone samples in methylmethacrylate: an improved method suitable for bone histomorphometry, histochemistry, and immunohistochemistry.J. Histochem. Cytochem.,45,307-313.
2. Erben, R.G.,Mosekilde, L.,Thomsen, J.S.,Weber, K.,Stahr, K.,Leyshon, A.,Smith, S.Y.,Phipps, R.(2002).Prevention of bone loss in ovariectomized rats by combined treatment with risedronate and 1α,25-dihydroxyvitamin D3.J. Bone Miner. Res.,17,1498-1511.
3. Furuichi, H.,Fukuyama, R.,Izumo, N.,Fujita, T.,Kohno, T.,Nakamuta, H.,Koida, M.(2000).Bone-anabolic effect of salmon calcitonin on glucocorticoid-induced osteopenia in rats. Bio. Pharm.Bull.,23,946-951.
4. Hara, K.,Kobayasi, M.,Akiyama, Y.(2002).Vitamin K2 (menatetrenone) inhibits bone loss induced by prednisolone partly through enhancement of bone formation in rats.Bone,31,575-581.
5. Iwamoto, J.,Seki, A.,Takeda, T.,Sato, Y.,Yamada, H.,Shen, C.L.,Yeh, J.K.(2006).Preventive effects of risedronate and calcitriol on cancellous osteopenia in rats treated with high-dose glucocorticoid.Exp. Anim.,55,349-355.
6. Iwamoto, J.,Seki, A.,Takeda, T.,Sato, Y.,Yamada, H.,Shen, C.L.,Yeh, J.K.(2006).Comparative effects of risedronate and calcitriol on cancellous bone in rats with glucocorticoid-induced osteopenia.J. Nutr. Sci. Vitaminol.,52,21-27.
7. Manolagas, S.C.,Weinstein, R.S.(1999).New developments in the pathogenesis and treatment of steroid-induced osteoporosis.J. Bone Miner. Res.,14,1061-1066.
8. Nitta, T.,Fukushima, T.,Nakamuta, H.,Koida, M.(1999).Glucocorticoid-induced secondary osteopenia in female rats: a time course study as compared with ovariectomy-induced osteopenia and response to salmon calcitonin.Jpn. J. Pharmacol.,79,379-386.
9. Noa, M.,Mendoza, S.,Mas, R.,Mendoza, N.,Leon, F.(2004).Effect of D-003, a mixture of very high molecular weight aliphatic acids, on prednisolone-induced osteoporosis in Sprague-Dawley rats.Drugs R. D.,5,281-290.
10. Ortoft, G.,Oxlund, H.(1996).Qualitative alterations of cortical bone in female rats after long-term administration of growth hormone and glucocorticoid.Bone,18,581-590.
11. Otomo, H.,Sakai, A.,Ikeda, S.,Tanaka, S.,Ito, M.,Phipps, R.J.,Nakamura, T.(2004).Regulation of mineral-to-matrix ratio of lumbar trabecular bone in ovariectomized rats treated with risedronate in combination with or without vitamin K2.J. Bone Miner. Metab.,22,404-414.
12. Parfitt, A.M.,Drezner, M.K.,Glorieux, F.H.,Kanis, J.A.,Malluche, H.,Meunier, P.J.,Ott, S.M.,Recker, R.R.(1987).Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASMBR Histomorphometry Nomenclature Committee.J. Bone Miner. Res.,2,595-610.
13. Shen, V.,Birchman, R.,Liang, X.G.,Wu, D.D.,Lindsay, R.,Dempster, D.W.(1997).Prednisolone alone, or in combination with estrogen or dietary calcium deficiency or immobilization, inhibits bone formation but does not induce bone loss in mature rats.Bone,21,345-351.
14. Shiraishi, A.,Takeda, S.,Masaki, T.,Higuchi, Y.,Uchiyama, Y.,Kubodera, N.,Sato, K.,Ikeda, K.,Nakamura, T.,Matsumoto, T.,Ogata, E.(2000).Alfacalcidol inhibits bone resorption and stimulate formation in an ovariectomized rat model of osteoporosis: distinct actions from estrogen.J. Bone Miner. Res.,15,770-779.
15. Tanaka, Y.,Nakamura, T.,Nishida, S.,Suzuki, K.,Takeda, S.,Sato, K.,Nishii, Y.(1996).Effects of a synthetic vitamin D analog, ED-71, on bone dynamics and strength in cancellous and cortical bone in prednisolone-treated rats.J. Bone Miner. Res.,11,325-336.
16. van Staa, T.P.,Leufkens, H.G.,Abenhaim, L.,Zhang, B.,Cooper, C.(2000).Use of oral corticosteroids and risk of fractures.J. Bone Miner. Res.,15,993-1000.
17. van Staa, T.P.,Leufkens, H.G.,Cooper, C.(2002).The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis.Osteoporos. Int.,13,777-787.

1. Seki, Azusa,Sato, Yoshihiro,Iwamoto, Jun(2014).Effect of Intermittent Administration of hPTH(1-34) on Cortical Bone Geometry in Rats Treated with High-Dose Glucocorticoids.中國生理學雜誌,57(5),231-237.